Records 1-15 (of 15 Records) |
Query Trace: MUC5B[original query] |
---|
Are MUC5B and TERT mutations genetic risk factors for pulmonary fibrosis in individuals with severe COVID-19? Yetkin Nur Aleyna, et al. Tuberkuloz ve toraks 2023 0 0. (1) 34-40 |
COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B. García-Carmona Salvador, et al. Current issues in molecular biology 2022 0 0. (8) 3283-3290 |
A MUC5B Gene Polymorphism, rs35705950-T Confers Protective Effects Against COVID-19 Hospitalization but not Severe Disease or Mortality. Verma Anurag, et al. American journal of respiratory and critical care medicine 2022 0 0. |
A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program. Verma Anurag, et al. PLoS genetics 2022 0 0. (4) e1010113 |
The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population. van Moorsel Coline H M, et al. Frontiers in medicine 2021 0 0. 668024 |
Mapping the human genetic architecture of COVID-19: an update The COVID-19 Host Genetics Initiative, MEDRXIV, November 11, 2021
The Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a major public health threat especially in countries with low vaccination rates. To better understand the biological underpinnings of SARS-CoV-2 infection and COVID-19 severity we formed the COVID19 Host Genetics Initiative. Here we present GWAS meta-analysis of up to 125,584 cases and over 2.5 million controls across 60 studies from 25 countries, adding 10 new genome-wide significant loci to the 13 we previously identified1. Genes in novel loci include SFTPD, MUC5B and ACE2, reveal compelling insights regarding disease susceptibility and severity.
|
A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program. Verma Anurag, et al. medRxiv : the preprint server for health sciences 2021 0 0. |
A MUC5B gene polymorphism, rs35705950-T, confers protective effects in COVID-19 infection A Verma et al, MEDRXIV, September 29, 2021 |
Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients. Hammoudeh Sarah Musa, et al. Frontiers in immunology 2021 0 0. 595150 |
Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung. Xu Fuyi, et al. Frontiers in immunology 2021 0 0. 607314 |
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity. Fadista João, et al. EBioMedicine 2021 3 0. 103277 |
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer Gayatri R, et al. Frontiers in genetics 2020 0 0. 861 |
The
MUC5B Promotor Polymorphism Associates with Severe COVID-19 in the European Population Moorsel, Coline H M Van et al. SSRN December 15 2020 |
The MUC5B promotor polymorphism associates with severe COVID-19 van Moorsel CH, et al. medRxiv, May 16, 2020. |
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity Fadista J, et al. medRxiv, Dec 16, 2020. |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 19, 2024
- Content source: